Taking people in Hollandia1. fázis
Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
Key facts
- Where
- Leiden, HollandiaSee the site
- Phase
- 1. fázis
Where in Hollandia
- Centre for Human Drug ResearchLeiden, HollandiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nrg Therapeutics Limited
- Trial code
- EU 2025-523872-22-00
- Record updated
- 2026. július 9.